Team:HKU HongKong/Project/Background.html
From 2012.igem.org
(Difference between revisions)
Line 486: | Line 486: | ||
</ul> | </ul> | ||
<p> </p> | <p> </p> | ||
- | + | <h2 style="font-variant: normal; vertical-align: baseline; clear: left; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin: 0.7em 0px; padding: 0px"> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
<span style="font-weight: 400; text-decoration:underline"> | <span style="font-weight: 400; text-decoration:underline"> | ||
<font face="Trebuchet MS" size="6">Abstract</font></span></h2> | <font face="Trebuchet MS" size="6">Abstract</font></span></h2> | ||
+ | <p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: rgb(85, 85, 85); font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | ||
+ | </p> | ||
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | <p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | ||
HKU’s iGEM team aims to introduce | HKU’s iGEM team aims to introduce | ||
Line 545: | Line 532: | ||
regarded as a potential implication of HKU’s iGEM project. | regarded as a potential implication of HKU’s iGEM project. | ||
- | + | <p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; vertical-align: baseline; color: rgb(85, 85, 85); font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | |
+ | <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"> | ||
<u><font face="Trebuchet MS"> | <u><font face="Trebuchet MS"> | ||
<b><font size="6" color="#232323">M</font></b><font size="6" color="#232323">aterials | <b><font size="6" color="#232323">M</font></b><font size="6" color="#232323">aterials | ||
Line 553: | Line 541: | ||
<i> | <i> | ||
<font color="#232323">Cloning and expressing pvdQ in E. coli</font></i></p> | <font color="#232323">Cloning and expressing pvdQ in E. coli</font></i></p> | ||
- | + | <p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">pvdQ was amplified from genomic DNA of Pseudomonas | |
- | + | ||
- | + | ||
Aeruginosa. A functional biobrick is constructed by combining pvdQ and | Aeruginosa. A functional biobrick is constructed by combining pvdQ and | ||
some regulatory elements (such as promoter and terminator). The | some regulatory elements (such as promoter and terminator). The | ||
Line 569: | Line 555: | ||
<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"> | <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"> | ||
<font color="#232323"><i>Testing the inhibitory effect</i></font></p> | <font color="#232323"><i>Testing the inhibitory effect</i></font></p> | ||
- | <p style="text-align: | + | <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"> |
- | + | <font color="#232323" face="Tahoma" size="2">The growth rate of monospecies biofilm of <i> | |
- | + | Pseudomonas putida</i> is used to reflect the inhibitory effect of | |
- | Pseudomonas putida is used to reflect the inhibitory effect of | + | engineered <i>Escherichia coli</i>. This is because the major AHLs |
- | engineered Escherichia coli. This is because the major AHLs | + | |
secreted by it involve 3-oxo-C12, which is a AHL that can be degraded by | secreted by it involve 3-oxo-C12, which is a AHL that can be degraded by | ||
PvdQ and is also the major AHL produced in Pseudomonas areuginosa, the | PvdQ and is also the major AHL produced in Pseudomonas areuginosa, the | ||
- | pathogenic microorganism. pvdQ expressing E. coli will be mixed | + | pathogenic microorganism. <i>pvdQ</i> expressing E. coli will be mixed |
with Pseudomonas putida and grown on agar plate. The reduction in | with Pseudomonas putida and grown on agar plate. The reduction in | ||
biofilm formation will be assayed by crystal violet assay. The next part | biofilm formation will be assayed by crystal violet assay. The next part | ||
of the experiment is to add engineered E. coli to different | of the experiment is to add engineered E. coli to different | ||
phases of biofilm to validate the role of AHLs in biofilm formation.</font></p> | phases of biofilm to validate the role of AHLs in biofilm formation.</font></p> | ||
- | |||
- | |||
- | |||
- | |||
</body> | </body> | ||
+ | |||
</html> | </html> |
Revision as of 05:19, 23 September 2012